← Back to Search

SMSH + TIP-C for Cancer Survivors' Well-being

N/A
Recruiting
Led By Chris Segrin, Ph.D.
Research Sponsored by University of Arizona
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up the gsds will be captured at baseline, during the 16 weekly calls and during the two exit interviews at weeks 17 and 24.
Awards & highlights

Study Summary

This trial is testing whether the SMSH and TIP-C interventions can improve cancer survivors’ and caregivers’ physical and psychological symptoms and quality of life.

Who is the study for?
This trial is for adult cancer survivors who've finished treatment within the last 2 years and their caregivers. Participants must have telephone access, not be in therapy, be able to do daily tasks, and understand English or Spanish. Caregivers can be of any relation.Check my eligibility
What is being tested?
The study tests two phone-based supports: a Symptom Management and Survivorship Handbook (SMSH) and Telephone Interpersonal Counseling (TIP-C), compared with receiving an NCI brochure on managing post-treatment needs.See study design
What are the potential side effects?
Since this trial involves informational handbooks and counseling over the phone rather than medication, there are no direct medical side effects. However, discussing sensitive topics might cause emotional discomfort.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~the gsds will be captured at baseline, during the 16 weekly calls and during the two exit interviews at weeks 17 and 24.
This trial's timeline: 3 weeks for screening, Varies for treatment, and the gsds will be captured at baseline, during the 16 weekly calls and during the two exit interviews at weeks 17 and 24. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Depression and Anxiety of Survivors' and Caregivers'
Change in Number and Distressed Associated with Survivors' and Caregivers' Symptoms
Secondary outcome measures
Change in Survivors' and Caregivers' health services use: Unscheduled and scheduled visits
Survivors' and Caregivers' health services use: The American Society of Clinical Oncology Survivorship Guidelines

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention ArmExperimental Treatment1 Intervention
Adaptive Need-based Sequence
Group II: Attention controlActive Control1 Intervention
This group will be participants that were randomized to the "Attention control" arm and will not receive the SMSH + TIP-C adaptive intervention.

Find a Location

Who is running the clinical trial?

University of ArizonaLead Sponsor
512 Previous Clinical Trials
147,589 Total Patients Enrolled
3 Trials studying Cancer Survivors
286 Patients Enrolled for Cancer Survivors
American Cancer Society, Inc.OTHER
224 Previous Clinical Trials
110,245 Total Patients Enrolled
1 Trials studying Cancer Survivors
217 Patients Enrolled for Cancer Survivors
Chris Segrin, Ph.D.Principal InvestigatorUniversity of Arizona

Media Library

Adaptive Symptom Management and Survivorship Handbook (SMSH) and Telephone Interpersonal Counseling (TIP-C) Clinical Trial Eligibility Overview. Trial Name: NCT05360498 — N/A
Cancer Survivors Research Study Groups: Intervention Arm, Attention control
Cancer Survivors Clinical Trial 2023: Adaptive Symptom Management and Survivorship Handbook (SMSH) and Telephone Interpersonal Counseling (TIP-C) Highlights & Side Effects. Trial Name: NCT05360498 — N/A
Adaptive Symptom Management and Survivorship Handbook (SMSH) and Telephone Interpersonal Counseling (TIP-C) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05360498 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any openings currently available for enrolment in this clinical experiment?

"Affirmative. According to clinicaltrials.gov, this medical trial which was initially posted on August 22nd 2022 is actively seeking participants. 212 individuals need to be enrolled from one single site for the study's completion."

Answered by AI

What is the scope of recruitment for this trial?

"Affirmative. Clinicaltrials.gov states that the recruitment phase of this trial is active, with a posting date on August 22nd 2022 and most recent update on September 2nd 2022. Currently, 212 participants are being sought for this study at one medical centre."

Answered by AI
~109 spots leftby Dec 2025